Journals in Toxicology

41-44 of 44 results in All results

Toxicology and Applied Pharmacology

ISSN: 0041-008X
5 Year impact factor: 4
Impact factor: 3.8

Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.TAAP also issues a standing call for outstanding Invited Review Articles. Potential authors should contact the Editor-In-Chief and complete an Invited Review Proposal Form before preparing or submitting their Review Article. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Toxicology in Vitro

ISSN: 0887-2333
5 Year impact factor: 3.3
Impact factor: 3.2

Affiliated with the American Association for Cellular and Computational Toxicology and the European Society for Toxicology in Vitro. Toxicology in Vitro publishes original research papers, reviews and workshop reports focusing on the application and use of in vitro and in silico systems for toxicological evaluations (collectively described as New Approach Methodologies (NAM)). This includes the utilisation or the development of NAMs for assessing the potential adverse effects of chemicals for human safety assessment. In vitro techniques include primary cells, tissue slices, cell lines and stem cells (adult, embryonic and induced Pluripotent cells) or subcellular preparations thereof. Our journal strongly supports the Reduction, Refinement and Replacement (3R) of animals in toxicology evaluations. This is a wide topic and thus we have certain preferences including: Development of in vitro techniques and their application to research and regulatory use (i.e. 3R principle. Mechanistic underpinning of data. Ability to translate outcome to human safety assessment. We strongly encourage : The use of normal (non-transformed) human cells (where appropriate). Reporting the Short Tandem Repeat (STR) profile of the cells used (especially when cells have been provided as a gift or generated in house). Free access to raw (or primary) data. Appropriate model characterisation. The use (or reduction) of animal free components, including serum. [Especially when the system was already developed under such conditions, such as the HK-2 cell line]. Attention to detailed methodology and appropriate statistics. [Readers need to know how you did the experiment, how many times, how many replicates etc?] Reporting the source of the compounded tested, catalogue no. and lot no. Where the chemical has been purified or synthesised a full analytical report is expected. Quantification of compounds in exposure medium and/or cells over time (biokinetics). We do not accept solely in vivo investigations and rarely accept animal in vivo, in vitro hybrid papers, except where the animal data was critical in the interpretation or validation of the in vitro data (and not merely confirmatory). We generally discourage investigations relating: Unidentified mixtures - for example in plant extracts. Solely pharmacological investigations (e.g. demonstrating your chemical kills cancer cells in vitro is not generally acceptable). Use of non-human cells when human equivalents exist and are available. The lack of adherence to established protocols, without direct explanation. Reporting cytotoxicity alone, with no mechanistic underpinning and/or no estimation of chemical exposure.

Toxicon

ISSN: 0041-0101
5 Year impact factor: 2.8
Impact factor: 2.8

Toxicon is affiliated with The Brazilian Society of Toxinology, The International Society on Toxinology and The North American Society of Toxinology. Toxicon is dedicated to all areas related to natural toxins and publishes peer-reviewed manuscripts describing novel findings of broad interest and importance to the toxinology community. Articles that further the understanding and knowledge of toxinology are particularly welcomed, as are review articles on toxinology. Submissions on Toxinology, Pharmacology, Immunology, Biochemistry, Health, Genetics and Molecular Biology (General) are particularly welcomed. The journal publishes articles on the following topics: original research on toxins derived from animals, plants or microorganisms novel findings related to the chemical, pharmacological, toxicological or immunological properties of natural toxins molecular biological studies of toxins and related genes from poisonous and venomous organisms that advance understanding of the role or function of toxins the use of toxins as tools in studying biological processes the translational application of toxins, for example as pharmacological tools, drugs or insecticides venom and antivenom issues clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained epidemiological studies on envenoming or poisoning, provided they highlight a previously unrecognized medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning properly designed prospective community-based surveys Toxicon does not accept submissions on retrospective surveys of hospital records, especially those lacking species identification, or articles describing well-known activities of venoms, such as antibacterial, anticancer or analgesic activities, without any attempt to define the mechanism of action or purify the active component(s). Toxicon: X is the open access companion for Toxicon.

Toxicon: X

ISSN: 2590-1710

Toxicon: X is dedicated to all areas related to natural toxins and is affiliated with The Brazilian Society of Toxinology, The International Society on Toxinology and The North American Society of Toxinology. Toxicon: X publishes peer-reviewed manuscripts describing novel findings of broad interest and importance to the toxinology community. Articles that further the understanding and knowledge of toxinology are particularly welcomed, as are review articles on toxinology. Submissions on Toxinology, Pharmacology, Immunology, Biochemistry, Health, Genetics and Molecular Biology (General) are particularly welcomed. The journal publishes articles on the following topics: original research on toxins derived from animals, plants or microorganisms novel findings related to the chemical, pharmacological, toxicological or immunological properties of natural toxins molecular biological studies of toxins and related genes from poisonous and venomous organisms that advance understanding of the role or function of toxins the use of toxins as tools in studying biological processes the translational application of toxins, for example as pharmacological tools, drugs or insecticides venom and antivenom issues clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained epidemiological studies on envenoming or poisoning, provided they highlight a previously unrecognized medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning properly designed prospective community-based surveys Toxicon: X does not accept submissions on retrospective surveys of hospital records, especially those lacking species identification, or articles describing well-known activities of venoms, such as antibacterial, anticancer or analgesic activities, without any attempt to define the mechanism of action or purify the active component(s). Toxicon: X is the open access companion for Toxicon.